Selected cytokine pathways in rheumatoid arthritis
The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–234 of 234
The disease formerly known as rheumatoid arthritis
Firestein, G. S. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4593 · Cited by 77
Hot, A., Zrioual, S., Lenief, V., & Miossec, P. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200867 · Cited by 76
Self-citationStimulus-Dependent Requirement for Granulocyte-Macrophage Colony-Stimulating Factor in Inflammation
Cook, A. D., Braine, E. L., & Hamilton, J. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4643 · Cited by 74
Suzuki, M., Hashizume, M., Yoshida, H., & Mihara, M. (2009) · Rheumatology International · doi:10.1007/s00296-009-0953-0 · Cited by 71
Chou, D. B., Sworder, B., Bouladoux, N., Roy, C. N., Uchida, A. M., Grigg, M., Robey, P. G., & Belkaid, Y. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1011527 · Cited by 71
Suzuki, M., Hashizume, M., Yoshida, H., Shiina, M., & Mihara, M. (2010) · Cytokine · doi:10.1016/j.cyto.2010.03.017 · Cited by 69
Ma, Y., Thornton, S., Boivin, G. P., Hirsh, D., Hirsch, R., & Hirsch, E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199810)41:10<1798::aid-art11>3.0.co;2-l · Cited by 68
Byström, J., Clanchy, F. I. L., Taher, T. E. I., Mangat, P. K., Jawad, A. S., Williams, R. O., & Mageed, R. A. (2016) · Cytokine · doi:10.1016/j.cyto.2016.09.001 · Cited by 68
Translating Molecular Insights in Autoimmunity into Effective Therapy
Feldmann, M. (2008) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082708-100732 · Cited by 67
Plater-Zyberk, C., Joosten, L. A. B., Helsen, M. M., Koenders, M. I., Baeuerle, P. A., & van den Berg, W. B. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.085431 · Cited by 64
GM-CSF but Not IL-17 Is Critical for the Development of Severe Interstitial Lung Disease in SKG Mice
Shiomi, A., Usui, T., Ishikawa, Y., Shimizu, M., Murakami, K., & Mimori, T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303255 · Cited by 62
Noack, M., Ndongo-Thiam, N., & Miossec, P. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1046-6 · Cited by 59
Self-citationArthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-joint.
Feige, U., Karbowski, A., Rordorf-Adam, C., & Pataki, A. (1989) · PubMed · Cited by 58
Rilonacept in the treatment of chronic inflammatory disorders
McDermott, M. (2009) · Drugs of today · doi:10.1358/dot.2009.45.6.1378935 · Cited by 56
Anti cytokine therapy in chronic inflammatory arthritis
Thompson, C., Davies, R., & Choy, E. (2016) · Cytokine · doi:10.1016/j.cyto.2016.07.015 · Cited by 54
van Nieuwenhuijze, A. E. M., van de Loo, F. A. J., Walgreen, B., Bennink, M. B., Helsen, M. M. A., van den Bersselaar, L., Wicks, I. P., van den Berg, W. B., & Koenders, M. I. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0683-5 · Cited by 53
Secukinumab for rheumatology: development and its potential place in therapy
Koenders, M., & van den Berg, W. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s105263 · Cited by 53
Toh, M., Kawashima, M., Hot, A., Miossec, P., & Miossec, P. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.111757 · Cited by 52
Self-citationMeasurement of colony-stimulating factors in synovial fluid: potential clinical value
Bell, A. L., Magill, M. K., McKane, W. R., Kirk, F., & Irvine, A. E. (1995) · Rheumatology International · doi:10.1007/bf00262295 · Cited by 51
Uchiyama, Y., Yorozu, K., Hashizume, M., Moriya, Y., & Mihara, M. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1159 · Cited by 50
Plater-Zyberk, C., Joosten, L. A. B., Helsen, M. M., Hepp, J., Baeuerle, P. A., & van den Berg, W. B. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057182 · Cited by 49
Burmester, G. R., Durez, P., Shestakova, G., Genovese, M. C., Schulze-Koops, H., Li, Y., Wang, Y. A., Lewitzky, S., Koroleva, I., Berneis, A. A., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kev258 · Cited by 45
Cowburn, A. S., Summers, C., Dunmore, B. J., Farahi, N., Hayhoe, R. P. G., Print, C. G., Cook, S. J., & Chilvers, E. R. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0101oc · Cited by 45
Hematopoietic colony-stimulating factors: new players in tumor–nerve interactions
Stösser, S., Schweizerhof, M., & Kuner, R. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0697-z · Cited by 42
Lawlor, K. E., Wong, P. K. K., Campbell, I. K., van Rooijen, N., & Wicks, I. P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21495 · Cited by 40
Ndongo-Thiam, N., & Miossec, P. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207110 · Cited by 37
Self-citationGeiler, J., & McDermott, M. (2010) · PubMed · Cited by 36
The Src-Like Adaptor Protein Regulates GM-CSFR Signaling and Monocytic Dendritic Cell Maturation
Liontos, L., Dissanayake, D., Ohashi, P. S., Weiss, A., Dragone, L. L., & McGlade, C. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903292 · Cited by 36
Liu, B., Tan, W., Barsoum, A. L., Gu, X., Chen, K., Huang, W., Ramsay, A. J., Kolls, J. K., & Schwarzenberger, P. O. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.06.004 · Cited by 36
Arner, E. C., Harris, R. R., Meo, T. M. D., Collins, R. C., & Galbraith, W. (1995) · PubMed · Cited by 30
The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy
Tarnowski, M., Paradowska‐Gorycka, A., Dąbrowska‐Żamojcin, E., Czerewaty, M., Słuczanowska-Głąbowska, S., & Pawlik, A. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1121233 · Cited by 27
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
Lazzerini, P. E., Capecchi, P. L., Guidelli, G. M., Selvi, E., Acampa, M., & Pasini, F. L. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s99898 · Cited by 22
Ndongo-Thiam, N., Clement, A., Pin, J., Razanajaona, D., & Miossec, P. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209149 · Cited by 17
Self-citationWarrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Cited by
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
“As RA progresses, immune cells and synovial fibroblasts produce a proinflammatory environment in the joint (306, 307) leading to joint destruction (302).”
BackgroundZhang, Q., Dehaini, D., Zhang, Y., Zhou, J., Chen, X., Zhang, L., Fang, R. H., Gao, W., & Zhang, L. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0254-4 · Cited by 958
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue, C., Yao, Q., Gu, X., Shi, Q., Yuan, X., Chu, Q., Bao, Z., Lu, J., & Li, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01468-7 · Cited by 699
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
Metadata
- Authors
- Noack, M., & Miossec, P.
- Venue
- Seminars in Immunopathology
- Published
- 2017-02-17
- Volume
- 39
- Issue
- 4
- Pages
- 365-383
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- OpenAlex
- W2589082990
- Cited by
- 303
- References
- 234
- FWCI
- 21.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.